Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Clinical trial NCT02876107 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02876107
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Carcinoma Breast Lump Edema Erythema Estrogen Receptor Negative HER2/Neu Negative Inflammatory Breast Carcinoma Invasive Breast Carcinoma Peau d'Orange Progesterone Receptor Negative Triple-Negative Breast Carcinoma

Start date: 2016-10-06
Primary completion: 2027-10-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.